arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

OmniAb, Inc.

OABI
$4.82 ▼ -0.35 (-6.86%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
28 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

OmniAb, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $623.2M
Dividend Yield —
Revenue Growth 78.3% ↘
Op. Margin -409.9% ↘
ROIC -6.5% ↘
FCF / Share $0.08 ↗
Trailing P/E —
Price / Book 2.8x
FCF Yield 1.7%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.99M
↑ +78.3% —
Net Income Profit after all expenses
$-7.71M
↑ +57.7% —
Operating Margin Operating profit as % of sales
-409.9%
↓ -728.5% 0th
FCF / Share Free cash flow per share
$0.08
↑ +310.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Returns ↓
26
Cash Quality ↑
43

Dividend History

Dividend / share · sourced from SEC filings
$2.50 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 28 quarters